• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305-19
Device Problems Structural Problem (2506); Patient-Device Incompatibility (2682)
Patient Problems Endocarditis (1834); Hemorrhage/Bleeding (1888); Thrombus (2101); Regurgitation (2259); Thromboembolism (2654)
Event Date 08/01/2002
Event Type  Injury  
Manufacturer Narrative
Citation: eichinger et al.European experience with the mosaic bioprosthesis.J thorac cardiovasc surg.2002 aug;124(2):333-9.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding prospective evaluation of the clinical and hemodynamic performance of the mosaic bioprosthesis.All data were collected from multiple centers between 1994 to may 1999.The study population included 561 patients (predominantly male, mean age 70 years), all of which were implanted with medtronic mosaic bioprosthesis (no serial numbers provided) in the atrial (461) or mitral position (100).Among all patients, adverse events included: structural valve deterioration, endocarditis, thromboembolism, nonstructural valve dysfunction, valve thrombosis, paravalvular leak (pvl), anti-thromboembolic hemorrhage, and reoperation or explant.Based on the available information medtronic product was associated with the adverse event(s).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8493920
MDR Text Key141305813
Report Number2025587-2019-01160
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 04/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305-19
Device Catalogue Number305-19
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age70 YR
-
-